125 related articles for article (PubMed ID: 30527091)
1. Range optimization for target and organs at risk in dynamic adaptive passive scattering proton beam therapy - A proof of concept.
Moriya S; Tachibana H; Hotta K; Nakamura N; Sakae T; Akimoto T
Phys Med; 2018 Dec; 56():66-73. PubMed ID: 30527091
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of dynamic adaptive passive scattering proton therapy with computed tomography image guidance in the lung.
Moriya S; Tachibana H; Hotta K; Nakamura N; Sakae T; Akimoto T
Med Phys; 2017 Sep; 44(9):4474-4481. PubMed ID: 28665491
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of CT-image guidance in proton therapy for liver cancer and the importance of daily dose monitoring for tumors and organs at risk.
Maeda Y; Kobashi K; Sato Y; Tamamura H; Yamamoto K; Matsushita K; Sasaki M; Tatebe H; Asahi T; Matsumoto S; Takamatsu S; Miyazaki K; Fujimoto R; Uchinami Y; Katoh N; Aoyama H
Med Phys; 2023 Jun; 50(6):3274-3288. PubMed ID: 37099416
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric feasibility of real-time MRI-guided proton therapy.
Moteabbed M; Schuemann J; Paganetti H
Med Phys; 2014 Nov; 41(11):111713. PubMed ID: 25370627
[TBL] [Abstract][Full Text] [Related]
5. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
[TBL] [Abstract][Full Text] [Related]
6. Positioning accuracy and daily dose assessment for prostate cancer treatment using in-room CT image guidance at a proton therapy facility.
Maeda Y; Sato Y; Minami H; Yasukawa Y; Yamamoto K; Tamamura H; Shibata S; Bou S; Sasaki M; Tameshige Y; Kume K; Ooto H; Kasahara S; Shimizu Y; Saga Y; Omoya A; Saitou M
Med Phys; 2018 May; 45(5):1832-1843. PubMed ID: 29532489
[TBL] [Abstract][Full Text] [Related]
7. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
[TBL] [Abstract][Full Text] [Related]
8. Feasibility study of range-based registration using daily cone beam CT for intensity-modulated proton therapy.
Yao W; Krasin MJ; Farr JB; Merchant TE
Med Phys; 2018 Mar; 45(3):1191-1203. PubMed ID: 29360157
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
Meerschaert R; Nalichowski A; Burmeister J; Paul A; Miller S; Hu Z; Zhuang L
J Appl Clin Med Phys; 2016 Nov; 17(6):323-333. PubMed ID: 27929505
[TBL] [Abstract][Full Text] [Related]
10. Reformulated McNamara RBE-weighted beam orientation optimization for intensity modulated proton therapy.
Ramesh P; Lyu Q; Gu W; Ruan D; Sheng K
Med Phys; 2022 Apr; 49(4):2136-2149. PubMed ID: 35181892
[TBL] [Abstract][Full Text] [Related]
11. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
12. A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.
Kurz C; Landry G; Resch AF; Dedes G; Kamp F; Ganswindt U; Belka C; Raaymakers BW; Parodi K
Phys Med Biol; 2017 Oct; 62(21):8470-8482. PubMed ID: 29047455
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric advantages of proton therapy compared with photon therapy using an adaptive strategy in cervical cancer.
van de Schoot AJ; de Boer P; Crama KF; Visser J; Stalpers LJ; Rasch CR; Bel A
Acta Oncol; 2016 Jul; 55(7):892-9. PubMed ID: 26934821
[TBL] [Abstract][Full Text] [Related]
14. Deformed dose restoration to account for tumor deformation and position changes for adaptive proton therapy.
Miyazaki K; Fujii Y; Yamada T; Kanehira T; Miyamoto N; Matsuura T; Yasuda K; Uchinami Y; Otsuka M; Aoyama H; Takao S
Med Phys; 2023 Feb; 50(2):675-687. PubMed ID: 36502527
[TBL] [Abstract][Full Text] [Related]
15. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
16. Proton therapy of prostate cancer by anterior-oblique beams: implications of setup and anatomy variations.
Moteabbed M; Trofimov A; Sharp GC; Wang Y; Zietman AL; Efstathiou JA; Lu HM
Phys Med Biol; 2017 Mar; 62(5):1644-1660. PubMed ID: 28166057
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
Qin A; Sun Y; Liang J; Yan D
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
[TBL] [Abstract][Full Text] [Related]
18. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
Stützer K; Lin A; Kirk M; Lin L
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
[TBL] [Abstract][Full Text] [Related]
19. Improving workflow for adaptive proton therapy with predictive anatomical modelling: A proof of concept.
Zhang Y; Alshaikhi J; Amos RA; Lowe M; Tan W; Bär E; Royle G
Radiother Oncol; 2022 Aug; 173():93-101. PubMed ID: 35667573
[TBL] [Abstract][Full Text] [Related]
20. Assessment and management of interfractional variations in daily diagnostic-quality-CT guided prostate-bed irradiation after prostatectomy.
Liu F; Ahunbay E; Lawton C; Li XA
Med Phys; 2014 Mar; 41(3):031710. PubMed ID: 24593714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
